Table 5.
No. of patients (%) | |
---|---|
Monotherapy | 37/64 |
Polytherapy | 16/64 |
None | 11/64 |
Steroids | 19 (29.7%) |
Cyclosporine | 10 (15.6%) |
Dapsone | 9 (14.1%) |
Anti‐TNFα | 10 (15.6%) |
Other drugs | 11 (17.2%) |
No. of patients (%) | |
---|---|
Monotherapy | 37/64 |
Polytherapy | 16/64 |
None | 11/64 |
Steroids | 19 (29.7%) |
Cyclosporine | 10 (15.6%) |
Dapsone | 9 (14.1%) |
Anti‐TNFα | 10 (15.6%) |
Other drugs | 11 (17.2%) |